MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0112729
Turio Pharmaceuticals Private Limited
Turio Pharmaceuticals Private Limited - chemicals in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹16.81 Lakh
▲ 1265% YoY
Net loss · FY 2024
₹7,008
Net margin -0.4%
EBITDA · FY 2024
-₹7,008
EBITDA margin -0.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Turio Pharmaceuticals Private Limited
Data last updated:
Turio Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 29 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2019PTC136447. Its GSTIN is 36AAHCT5788J1ZL (Telangana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rekha Telukuntla (Managing Director) and Suresh Chaluvadi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 12 – 6 – 36/9/D/2 Shiva Shakti Nagar Moosapet Bharath Nagar Kukatpally, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.81 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹7,008 (net margin -0.4%) and EBITDA of -₹7,008 (EBITDA margin -0.4%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years.
Court records list 1 case involving the company, including 1 filed against it.
Turio Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0112729).
Company details
CIN U24299TG2019PTC136447
Registration Number 136447
Incorporation Date 29 October 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0112729
Key People
Rekha Telukuntla Managing Director Suresh Chaluvadi Director Telukuntla Sri Laxmi Director Recognitions & Rankings of Turio Pharmaceuticals
Contact details
Turio Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address12 – 6 – 36/9/D/2 Shiva Shakti Nagar Moosapet Bharath Nagar Kukatpally, Hyderabad, Telangana, India – 500018
- IndustryChemicals, Other Chemical Product, Manufacturing, Fine Chemicals And Other Chemical Products
To see the full contact details of Turio Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Turio Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Turio Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Turio Pharmaceuticals Private Limited, buy the company report.
Financials of Turio Pharmaceuticals Private Limited
FY 2024 filings availableTurio Pharmaceuticals Private Limited reported revenue of ₹16.81 Lakh (up 1265% YoY) for FY 2024.
Revenue · FY 2024
₹16.81 Lakh ▲ 1265%
Net loss · FY 2024
₹7,008 margin -0.4%
EBITDA · FY 2024
-₹7,008 margin -0.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▼ 30%
EBITDA CAGR growth
1 year
▲ 99%
3 years · compounded
▲ 29%
Revenue has declined at a compounded annual rate (CAGR) of 30% over three years. EBITDA rose 99% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7,008 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7,008 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.4% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Turio Pharmaceuticals Private Limited, buy the company report.
Board of directors of Turio Pharmaceuticals Private Limited
Turio Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Chaluvadi | Director | 23 Nov 2023 | 2 Years 11 Months | Current |
| Rekha Telukuntla | Managing Director | 17 Dec 2019 | 6 Years 10 Months | Current |
| Telukuntla Sri Laxmi | Director | 29 Oct 2019 | 7 Years 0 Months | Current |
Peer comparison
Turio Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anoush Pharmaceuticals India Private Limited | ₹16.94 Lakh (FY 2023) | 21.0% | Hoshiarpur, Punjab, India | |||
| We Doc Pharmaceuticals Private Limited | ₹16.85 Lakh (FY 2025) | -38.0% | Delhi, India | |||
| Shirama Pharmaceuticals Private Limited | ₹16.84 Lakh (FY 2024) | 85.0% | Varanasi, Uttar Pradesh, India | |||
| Turio Pharmaceuticals Private Limitedthis company | ₹16.81 Lakh (FY 2024) | -₹7,008 | -0.4% | 1265.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Turio Pharmaceuticals Private Limited, buy the company report.
Legal cases
Turio Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Glaxosmithkline Pharmaceuticals Limited | Disposed |
To see the full case history of Turio Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Turio Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Turio Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCT5788J1ZL | Telangana | Active | 04 Dec 2019 |
To see the full GST registrations and return filing status of Turio Pharmaceuticals Private Limited, buy the company report.
Recent activity
Turio Pharmaceuticals Private Limited has 9 board changes on record since 2019: 3 appointments and 6 cessations. The latest: Rekha Telukuntla ceased to be Director on 23 Jan 2024.
AGM
Turio Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Turio Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Rekha Telukuntla ceased to be Director.
Ceased
Telukuntla Sri Laxmi ceased to be Managing Director.
Appointed
Suresh Chaluvadi was appointed as Director.
Ceased
Sindhu Pasumarthi ceased to be Director.
Ceased
Swarajyalakshmi Rayapudi ceased to be Director.
Ceased
Berelly Swetha ceased to be Director.
Ceased
Bijayalaxmi Parida ceased to be Director.
Appointed
Rekha Telukuntla was appointed as Managing Director.
Appointed
Telukuntla Sri Laxmi was appointed as Director.
Incorporation
29 Oct 2019
Turio Pharmaceuticals Private Limited was registered on 29 Oct 2019 with Roc Hyderabad & aged 7 years 8 days as per MCA records.
Frequently asked questions
Turio Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 29 October 2019 (7+ years old) and is registered under CIN U24299TG2019PTC136447.
Turio Pharmaceuticals has 3 current directors:
- Rekha Telukuntla - Managing Director
- Suresh Chaluvadi - Director
- Telukuntla Sri Laxmi - Director
The latest financial statements of Turio Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Turio Pharmaceuticals is 36AAHCT5788J1ZL, registered in Telangana.
The CIN (Corporate Identification Number) of Turio Pharmaceuticals is U24299TG2019PTC136447. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Turio Pharmaceuticals has 1 court case on record: 1 filed against it.
Turio Pharmaceuticals was incorporated on 29 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Turio Pharmaceuticals by revenue are Anoush Pharmaceuticals India Private Limited, We Doc Pharmaceuticals Private Limited, Shirama Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).
Rekha Telukuntla ceased to be Director on 23 Jan 2024. Telukuntla Sri Laxmi ceased to be Managing Director on 23 Jan 2024. Suresh Chaluvadi was appointed as Director on 23 Nov 2023. Turio Pharmaceuticals has 9 board changes on record in total.
Yes, Turio Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0112729).
The registered office of Turio Pharmaceuticals is at 12 – 6 – 369D2 Shiva Shakti Nagar Moosapet Bharath Nagar Kukatpally, Hyderabad, Telangana, India – 500018.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages